{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:57:18Z","timestamp":1780631838589,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T00:00:00Z","timestamp":1169078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2007,10,25]]},"DOI":"10.1007\/s00431-006-0403-x","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T03:49:47Z","timestamp":1169005787000},"page":"1229-1236","source":"Crossref","is-referenced-by-count":24,"title":["Booster vaccination and 1-year follow-up of 4\u20138-year-old children with a reduced-antigen-content dTpa-IPV vaccine"],"prefix":"10.1007","volume":"166","author":[{"given":"Roland","family":"S\u00e4nger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Behre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Loch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Soemantri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Schmitz-Hauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"403_CR1","unstructured":"The Australian Immunisation Handbook, 8th edn (2003) National Health & Medical Research Council"},{"key":"403_CR2","first-page":"33","volume":"06","author":"Bulletin Epid\u00e9miologique Hebdomadaire. Calendrier vaccinal","year":"2003","unstructured":"Bulletin Epid\u00e9miologique Hebdomadaire. Calendrier vaccinal (2003) Avis du Conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France 06:33\u201337","journal-title":"Avis du Conseil sup\u00e9rieur d\u2019hygi\u00e8ne publique de France"},{"key":"403_CR3","unstructured":"Canadian Immunization Guide 6th edition (2002) Population and Public Health Branch, Centre for Infectious Disease Prevention and Control"},{"issue":"RR-13","key":"403_CR4","first-page":"1","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","unstructured":"Centers for Disease Control and Prevention (2000) Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations if the Advisory Committee on Immunization Practices (ACIP). MMWR 49 (RR-13):1\u20138","journal-title":"MMWR"},{"key":"403_CR5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1542\/peds.104.6.1381","volume":"104","author":"JD Cherry","year":"1999","unstructured":"Cherry JD, Olin P (1999) The science and fiction of pertussis vaccines. Pediatrics 104:1381\u20131384","journal-title":"Pediatrics"},{"key":"403_CR6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.vaccine.2004.06.012","volume":"23","author":"B Cheuvart","year":"2004","unstructured":"Cheuvart B, Burgess M, Zepp F, Mertsola J, Wolter M, Schuerman L (2004) Anti-diphtheria antibody seroprotection rates are similar 10\u00a0years after vaccination with dTpa or DTPa using a mathematical model. Vaccine 23:336\u2013342","journal-title":"Vaccine"},{"key":"403_CR7","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.vaccine.2004.04.027","volume":"22","author":"CL Collins","year":"2004","unstructured":"Collins CL, Salt P, McCathy N, Chantler T, Lane L, Hemme F, Diggle L, Buttery J, Kitchin NRE, Moxon ER, Pollard AJ (2004) Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22:4262\u20134269","journal-title":"Vaccine"},{"key":"403_CR8","first-page":"245","volume":"32","author":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut","year":"2003","unstructured":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (2003) Epidemiologisches Bull 32:245\u2013260","journal-title":"Epidemiologisches Bull"},{"key":"403_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0264-410X(93)90286-7","volume":"11","author":"M Granstrom","year":"1993","unstructured":"Granstrom M, Granstrom G (1993) Serological correlates in whooping cough. Vaccine 11:445\u2013448","journal-title":"Vaccine"},{"key":"403_CR10","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","volume":"23","author":"E Grimprel","year":"2005","unstructured":"Grimprel E, von Sonnenburg F, S\u00e4nger R, Abitbol V, Wolter JM, Schuerman LM (2005) Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Vaccine 23:3657\u20133667","journal-title":"Vaccine"},{"key":"403_CR11","unstructured":"Gustafsson L, Hallander HO, Olin P (2005) Seven year report. Pertussis surveillance in Sweden. Progress Report October 1997-September 2004. Avdelningen F\u00f6r Immunologi Och Vaccinologi Smittskyddsinstitutet"},{"key":"403_CR12","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/170.4.873","volume":"170","author":"Q He","year":"1994","unstructured":"He Q, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J (1994) Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 170:873\u2013877","journal-title":"J Infect Dis"},{"key":"403_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00006454-199304000-00005","volume":"12","author":"J Isacson","year":"1993","unstructured":"Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergard T (1993) How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 12:284\u2013288","journal-title":"Pediatr Infect Dis J"},{"key":"403_CR14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","volume":"100","author":"M Pichichero","year":"1997","unstructured":"Pichichero M, Deloria M, Rennels M, Anderson E, Edwards K, Decker M, Englund J, Steinhoff M, Deforest A, Meade B (1997) A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 100:772\u2013788","journal-title":"Pediatrics"},{"key":"403_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","volume":"14","author":"MB Rennels","year":"2003","unstructured":"Rennels MB (2003) Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Ped Infect Dis 14:196\u2013198","journal-title":"Semin Ped Infect Dis"},{"key":"403_CR16","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/S0264-410X(01)00230-4","volume":"19","author":"DW Scheifle","year":"2001","unstructured":"Scheifle DW, Halperin SA, Ferguson AC (2001) Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin test with vaccine antigens. Vaccine 19:4720\u20134726","journal-title":"Vaccine"},{"key":"403_CR17","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1542\/peds.112.6.e453","volume":"112","author":"DM Skowronski","year":"2003","unstructured":"Skowronski DM, Remple VP, Macnabb J, Pielak K, Patrick DM, Halperin SA, Scheifele D (2003) Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact. Pediatrics 112:e453\u2013e459","journal-title":"Pediatrics"},{"key":"403_CR18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","volume":"21","author":"J Storsaeter","year":"2003","unstructured":"Storsaeter J, Hallander HO, Gustafsson L, Olin P (2003) Low levels of anti pertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21:3542\u20133549","journal-title":"Vaccine"},{"key":"403_CR19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/01.inf.0000095198.75170.b6","volume":"22","author":"S Torvaldsen","year":"2003","unstructured":"Torvaldsen S, McIntyre PB (2003) Effect of the preschool pertussis booster on national notifications of disease in Australia. Pediatr Infect Dis J 22:956\u2013959","journal-title":"Pediatr Infect Dis J"},{"key":"403_CR20","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.107.2.e25","volume":"107","author":"AE Tozzi","year":"2001","unstructured":"Tozzi AE, Anemona A, Stefanelli P, Salmaso S, Atti ML, Mastrantonio P, Giammanco A, Progetto Pertosse Study Group (2001) Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 107:e25","journal-title":"Pediatrics"},{"key":"403_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00431-005-1650-y","volume":"164","author":"R Vergara","year":"2005","unstructured":"Vergara R, Tregnaghi M, Ussher J, Navarro S, R\u00fcttimann R, Potin M, Wolter J, Schuerman L (2005) Reduced-antigen dTpa-IPV vaccine as a booster for adolescents 10 to 14\u00a0years of age. Eur J Ped 164:377\u2013382","journal-title":"Eur J Ped"},{"key":"403_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/375820","volume":"37","author":"EJ Woo","year":"2003","unstructured":"Woo EJ, Burwen DR, Gatumu SNM, Ball R, the Vaccine Adverse Event Reporting System (VAERS) Working Group (2003) Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis 37:351\u2013358","journal-title":"Clin Infect Dis"},{"key":"403_CR23","unstructured":"World Health Organisation standard procedure for determining immunity to poliovirus using the microneutralization test (WHO\/EPI\/Gen 93.9)"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-006-0403-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-006-0403-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:25:54Z","timestamp":1559067954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-006-0403-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,18]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,10,25]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s00431-006-0403-x","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,18]]}}}